logo

For the Inventor, By the Inventor

Sakura, Japan

Takuo Aoyama

This inventor holds 6 USPTO granted patents. Top assignee: Torii & Co., Ltd.. Active years: 1984-1989.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Takuo Aoyama. Retrieved from https://idiyas.com/inventor/takuo-aoyama

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 7.8

ph-index = 3

Forward Citations = 67(Granted Patents)


Company Filing History:

goldMedal6 out of 26 
 
Torii & Co., Ltd.
 patents

Years Active: 1984-1989

Loading Chart...
6 patents (USPTO):Explore Patents
1. 4820730 - 6-amino-2-naphthyl 4-gusnichinobenzoate derivatives and pharmaceutical (1989-04-11),
2. 4777182 - 6-Amidino-2-naphthyl 4-guanidinobenzoate derivatives and pharmaceutical (1988-10-11),
3. 4634783 - Novel amidine compound (1987-01-06),
4. 4598077 - Amidine derivatives and cardiotonic compositions (1986-07-01),
5. 4563527 - Amidine compounds (1986-01-07),
6. 4490388 - Amidine compound and anticomplement agent comprising same (1984-12-25),

Title: Takuo Aoyama: Innovator in Pharmaceutical Compounds

Introduction

Takuo Aoyama is a distinguished inventor based in Sakura, Japan, known for his significant contributions to the pharmaceutical industry. With a remarkable portfolio of six patents, Aoyama focuses on innovative compounds that hold potential therapeutic applications.

Latest Patents

Among his latest inventions are the 6-amino-2-naphthyl 4-guanidinobenzoate derivatives and various amidine compounds. These compounds are noted for their utility as anti-trypsin, anti-plasmin, anti-kallikrein, anti-thrombin, and anti-complement agents, which can be administered orally. The amidine compounds can be synthesized through the reaction of a carboxylic acid compound or a reactive intermediate, coupled with 6-amidino-2-naphthol or its acid addition salt. These innovations provide promising avenues for advancing pharmaceutical treatments.

Career Highlights

Aoyama's work is primarily associated with Torii & Co., Ltd., where he applies his expertise to develop novel medications. His research is driven by an ambition to enhance therapeutic efficacy and patient outcomes in various medical conditions through innovative chemical compounds.

Collaborations

Throughout his career, Takuo Aoyama has collaborated with notable professionals in the field, including co-workers Toyoo Nakayama and Shigeki Nunomura. Their collective efforts contribute to advancing pharmaceutical research and fostering innovation within the industry.

Conclusion

Takuo Aoyama's contributions to the field of pharmaceuticals reflect a significant commitment to innovation. His patents not only highlight the potential of new chemical compounds but also illustrate the importance of collaboration in advancing scientific knowledge. As he continues his work at Torii & Co., Ltd., Aoyama remains an inspiring figure in the realm of pharmaceutical inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…